Preferential potentiation of paclitaxel and doxorubicin cytotoxicity in drug-resistant breast tumor cells by tesmilifene.
Bibliographic record
Abstract
5421 A phase III study of anthracycline-naive women with metastatic breast cancer by the National Cancer Institute of Canada Clinical Trials Group (MA.19) revealed that treatment of patients with doxorubicin in combination with N,N-Diethyl-2-[4-(Penylmethyl)Phenoxy]Ethanamine (tesmilifene) was superior to doxorubicin alone in terms of overall survival (P=0.021), with no difference seen in response rate or progression free survival (J. Clin. Oncol. 22: 269-276, 2004). One possible explanation for this observation may be that tesmilifene specifically increases the cytotoxicity of chemotherapy drugs only in rare drug-resistant cells, thus inhibiting the development of drug-resistant tumors over time. To assess this hypothesis, we examined in a clonogenic assay the effect of tesmilifene (at concentrations ranging from 0.1 to 6 μM) on the ability of doxorubicin or paclitaxel to kill wildtype MCF-7 breast tumor cells and isogenic MCF-7 cells resistant to doxorubicin or paclitaxel (MCF-7 DOX and MCF-7 TAX cells, respectively). Consistent with the above hypothesis, tesmilifene decreased the concentration at which 50% of MCF-7 TAX cells were killed by paclitaxel (the IC 50 ) in a dose-dependent manner by as much as 4-fold (at 6 μM tesmilifene), while having little effect or increasing the IC 50 for paclitaxel in wildtype MCF-7 cells, even at the highest concentration of tesmilifene. Cross resistance to doxorubicin in MCF-7 TAX cells was also reduced in a dose-dependent manner by as much as 4-fold by tesmilifene, while only slightly increasing the IC 50 for doxorubicin in wildtype MCF-7 cells at the highest concentration of tesmilifene. The IC 50 for doxorubicin was decreased by as much as 2.5-fold upon the addition of tesmilifene to MCF-7 DOX cells (also in a dose-dependent manner), with little change in the IC 50 for doxorubicin in wildtype cells. Since our MCF-7 TAX cell line overexpresses P-glycoprotein (P-gp), while our MCF-7 DOX cell line does not, it would appear that the effect of DPPE on the cytotoxicity of chemotherapy drugs in drug-resistant cells is not P-gp-specific, although this may be enhanced in P-gp-expressing cell lines. While accumulation of paclitaxel or doxorubicin was reduced in MCF-7 TAX and MCF-7 DOX cells, respectively, tesmilifene (at a 3 μM concentration) had no effect on the uptake of paclitaxel or doxorubicin into MCF-7, MCF-7 TAX , and MCF-7 DOX cells. Taken together, our data demonstrate that tesmilifene augments the cytotoxicity of paclitaxel and doxorubicin but only in drug-resistant cells through a mechanism unrelated to drug accumulation defects inherent in these cell lines.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".